PUBLISHER: The Business Research Company | PRODUCT CODE: 1650443
PUBLISHER: The Business Research Company | PRODUCT CODE: 1650443
Hyaluronic acid-based dermal fillers constitute a type of dermal filler designed for short-term use. Hyaluronic acid, known for its ability to attract water to the skin, enhances skin moisturization. Belotero and Restylane Silk, specific types of hyaluronic acid-based fillers, are utilized to address shallow and fine wrinkles, effectively preventing signs of aging.
The primary categories of hyaluronic acid-based dermal fillers include single-phase and duplex products. Single-phase products find widespread application in various skin-related procedures, addressing soft facial tissue irregularities. The uncross-linked hyaluronic acid in these products stimulates elastin and collagen production, resulting in a more youthful and healthier appearance of the skin. These fillers are employed in specialty and dermatology clinics, as well as hospitals, for diverse applications such as wrinkle removal, lip augmentation, rhinoplasty, and other aesthetic procedures.
The hyaluronic acid-based dermal fillers market research report is one of a series of new reports from The Business Research Company that provides hyaluronic acid-based dermal fillers market statistics, including hyaluronic acid-based dermal fillers industry global market size, regional shares, competitors with a hyaluronic acid-based dermal fillers market share, detailed hyaluronic acid-based dermal fillers market segments, market trends and opportunities, and any further data you may need to thrive in the hyaluronic acid-based dermal fillers industry. This hyaluronic acid-based dermal fillers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hyaluronic acid-based dermal fillers market size has grown rapidly in recent years. It will grow from $4.94 billion in 2024 to $5.52 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to aging population, rise in beauty consciousness, social media influence, proliferation of medical spas and aesthetic clinics, rise in e-commerce.
The hyaluronic acid-based dermal fillers market size is expected to see rapid growth in the next few years. It will grow to $8.45 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to increasing disposable income, rising consumer awareness about personal hygiene and grooming, increasing demand for personal care products, economic growth. Major trends in the forecast period include natural and organic formulations, combination therapies, minimally invasive procedures, advanced delivery techniques, integration of virtual consultations and telemedicine.
The growth of hyaluronic acid-based dermal fillers is being fueled by an increasing demand for non-invasive dermatology techniques. Unlike invasive tests that break the skin or enter the body, non-invasive treatments, such as those utilizing acid-based dermal fillers, are preferred for their minimal risks and long-lasting results. The American Society of Plastic Surgeons (ASPS) reported in February 2022 that over 17 million adults annually choose cosmetic surgeries, including minimally invasive options like body contouring, lasers, and injections. This rising demand is expected to boost the market for hyaluronic acid-based dermal fillers.
The growth of the hyaluronic acid-based dermal fillers market is further propelled by the increasing aging population. With an aging population characterized by a higher proportion of elderly individuals due to increased life expectancy and declining birth rates, hyaluronic acid-based dermal fillers provide a non-surgical solution for addressing signs of aging such as wrinkles and sagging skin. According to the World Health Organization (WHO), the global population aged 60 and above is projected to double by 2050, reaching 2.1 billion, while those aged 80 and older will triple, reaching 426 million. Consequently, the surge in the aging population is a key driver for the hyaluronic acid-based dermal fillers market.
Leading companies in the hyaluronic acid-based dermal fillers market are creating innovative solutions, such as JUVEDERM VOLUX XC, to deliver more effective facial contouring and enhance the structural definition of the jawline, providing longer-lasting and natural-looking results for patients seeking aesthetic treatments. For example, Allergan plc, a pharmaceutical company based in Ireland, introduced JUVEDERM VOLUX XC. This long-lasting hyaluronic acid (HA) filler is specifically designed to enhance facial contours and add volume to the jawline, meeting the rising consumer demand for aesthetic treatments that yield natural-looking outcomes. JUVEDERM VOLUX XC is the newest addition to the JUVEDERM Collection, offering a minimally invasive, non-surgical treatment option with minimal to no downtime.
Mmajor companies in the hyaluronic acid-based dermal fillers market are introducing OxiFree technology. This technology is designed to preserve long molecular hyaluronic acid (HA) chains, ensuring their integrity and effectiveness in various applications. In June 2022, Sinclair Pharma Ltd launched MaiLi, the world's first OxiFree Dermal Filler, incorporating patented OxiFree HA technology. This innovation involves crosslinking through 1,4-Butanediol diglycidyl ether (BDDE), resulting in a pliable, resilient gel known for its voluminous projection and long-lasting properties.
In October 2022, Prollenium Medical Technologies Inc., a Canada-based manufacturer and distributor of hyaluronic acid-based dermal fillers, acquired Soft Medical Aesthetics to enhance their portfolio, featuring Revanesse dermal fillers. The addition of SoftFil, a France-based manufacturer of hyaluronic acid-based dermal fillers, aims to strengthen safety and effectiveness in the field of aesthetic medicine, further expanding Prollenium's presence in the market.
Major companies operating in the hyaluronic acid-based dermal fillers market include Bohus Biotech AB, AbbVie Inc., Galderma Laboratories L.P., Merz Pharmaceuticals GmbH, Anika Therapeutics Inc., LG Chem Ltd., Bio plus Co. Ltd., Sculpt Luxury Dermal Fillers Ltd., Bioxis Pharmaceutical, Sinclair Pharma plc, Laboratories Vivacy SAS, Teoxane S.A., Suneva Medical Inc., Advanced Aesthetic Technologies Inc., Croma-Pharma GmbH, Cytophil Inc., DR. Korman Laboratories Ltd., Huons Global Co. Ltd., Revance Therapeutics Inc., TEOXANE Laboratories
North America was the largest region in the hyaluronic acid-based dermal fillers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hyaluronic acid-based dermal fillers market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the hyaluronic acid-based dermal fillers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The hyaluronic acid-based dermal fillers market consists of sales of fat grafting, permanent soft tissue filler, poly-l-lactic acid, calcium hydroxylapatite, and hyaluronic acid. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hyaluronic Acid-based Dermal Fillers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on hyaluronic acid-based dermal fillers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for hyaluronic acid-based dermal fillers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hyaluronic acid-based dermal fillers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.